Exelixis, Inc. (EXEL) SEC Filing 8-K Material Event for the period ending Thursday, February 28, 2019

Exelixis, Inc.

CIK: 939767 Ticker: EXEL

View differences made from one to another to evaluate Exelixis, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Exelixis, Inc..


Assess how Exelixis, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Exelixis, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: EXEL
CIK: 939767
Form Type: 8-K Corporate News
Accession Number: 0000939767-19-000059
Submitted to the SEC: Tue Mar 05 2019 5:02:18 PM EST
Accepted by the SEC: Tue Mar 05 2019
Period: Thursday, February 28, 2019
Industry: Commercial Physical And Biological Research
  1. Event for Officers

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: